DEDHAM, Mass.–(BUSINESS WIRE)–DoseSpot, a software-as-a-service (SaaS) platform that enables clinicians to electronically write and transmit prescriptions to pharmacies, has acquired the TreatRx segment of Bravado Health to strengthen and expand DoseSpot’s solution set for healthcare providers and help advance its position in the ePrescribing software integration market. The acquisition follows a strategic investment in January … [Read more…]

GenesisCare’s first MRIdian® in the U.S., one of only 28 in the U.S., will improve patient access to advanced technology that reduces the burden of treatment for patients with prostate, breast, or pancreatic tumors FORT MYERS, Fla.–(BUSINESS WIRE)–GenesisCare, one of the leading integrated cancer care providers in the United States, Australia, Spain, and the United … [Read more…]

TORONTO–(BUSINESS WIRE)–Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Friday, March 31, 2023 at 8:30am EST. The conference call will cover its second-quarter 2023 financial results. During the call, the Mednow team will provide an update on Mednow’s … [Read more…]

– Bicycle and Novartis will collaborate on the discovery and development of multiple targeted radioligand therapies in oncology – Bicycle will receive a $50 million upfront payment as well as potential milestones and tiered commercial royalties CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of … [Read more…]

 Gelesis has demonstrated strong demand for Plenity, helping over 200,000 people on their weight loss journeys since launch Company has filed with FDA to make Plenity available to Over the Counter (OTC), which should significantly broaden consumer access and reduce the cost to reach new members BOSTON–(BUSINESS WIRE)–$GLS #earnings–Gelesis Holdings, Inc. (NYSE: GLS) (“Gelesis” or … [Read more…]

— Distinguished biotech leaders bring expertise to support Switch Therapeutics’ ongoing growth and commitment to progressing its world class pipeline — — Craig Blanchette, Ph.D., Appointed Senior Vice President, Research — — Michael Wolfe Appointed Senior Vice President, Finance and Operations — SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Switch Therapeutics, a preclinical stage biotechnology company pioneering a … [Read more…]

$4.8 million funding from Vsquared Ventures, Practica Capital and Metaplanet, bringing total funding to over $8 million New capital will support a worldwide commercial organisation, enabling a direct U.S. presence Launch of new semi-permeable capsule technology to unlock breakthroughs in scientific discovery and innovation VILNIUS, Lithuania & DENVER–(BUSINESS WIRE)–Backed by international investors, Atrandi Biosciences is … [Read more…]

LONDON & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announced the appointment of Karen Harrison as Chief Operating Officer of its Therapeutics Division. In her new role, Karen will be responsible for supporting the research and development functions across Avacta’s Therapeutics Division, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “APAC HIV Rapid Test Kits Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The APAC HIV rapid test kits market was valued at $418.81 million in 2022 and is projected to reach at $487.70 billion in 2028, with a compound annual growth rate (CAGR) of 2.57%, during the study … [Read more…]

23Ingredients Menu Improves Physical and Mental Health BOULDER, Colo.–(BUSINESS WIRE)–When Alexia Parks won the first of six contracts to prepare and deliver 1-million meals to 350 sheltered homeless in Riverside County, CA, Parks knew that her bid was higher than that of a competing global food catering company. What the global company did not know … [Read more…]